Market Overview:
The global disease risk and health genetic test market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing prevalence of chronic diseases, technological advancements in disease risk and health genetic testing, and growing demand for personalized medicine. The global disease risk and health genetic test market by type is segmented into celiac disease, Parkinson’s disease, Alzheimer’s disease, other diseases. The celiac disease segment is expected to grow at the highest CAGR during the forecast period owing to the increasing incidence of gluten intolerance across the globe. The global Disease Risk & Health Genetic Test Market by application is segmented into online application and offline application. The online application segment dominates the market due to rising adoption of digital technologies for diagnosis purposes among patients worldwide.
Product Definition:
Disease risk and health genetic tests are used to determine a person's risk of developing certain diseases and conditions. The tests can also be used to help identify genes that may put a person at increased risk for health problems. Knowing about potential risks can allow people to make changes in their lifestyle or seek medical care that may help reduce their chances of developing a disease.
Celiac Disease:
Celiac disease (CD) is a chronic, progressive, and autoimmune disorder of the small intestine. The disease has two forms: non-infectious (celiac sprue) and infectious (celiac infection). Celiac sprue is an immune response to gluten that attacks the small intestine. CD affects 1 in every 133 people globally or around 3% of the global population.
Parkinson Disease:
Parkinson disease (PD) is a disorder of the central nervous system that affects the body’s motor systems, including the basal ganglia. PD is one of the most common neurodegenerative disorders and affects approximately 1 million people in America.
Application Insights:
The online application segment dominated the global disease risk and health genetic test market in 2017. This is attributed to factors such as rising prevalence of genetic diseases, increasing demand for carrier testing, and availability of a wide range of tests at low costs. For instance, 23andMe Testing Service offers over 150 different tests across seven categories- Health & Ancestry, Lifestyle & Relationships, DNA Test Kits ( paternity test), Genealogy & Family History, Research Studies- all available online free of charge to customers across the globe.
However, the offline application segment is expected to witness lucrative growth during the forecast period owing to factors such as an increase in awareness about these services among patients with a known history or family history associated with one or more genetic diseases; growing preference for face-to-face contact between healthcare professionals and patients; presence of dedicated centers providing disease risk information along with other related information regarding carrier screening.
Regional Analysis:
North America dominated the global disease risk and health genetic test market in 2017. The presence of a large number of players, high adoption rate for advanced technologies, and favorable reimbursement policies are some factors driving the regional market growth. Moreover, increasing awareness about these tests among patients is also expected to boost demand over the forecast period.
Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in research funding for diseases that can be prevented by early diagnosis will further drive this regional market over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily due to the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for disease risk and health genetic tests that can help in early diagnosis and treatment of these conditions.
- Growing awareness about personalized medicine: There is a growing awareness among people about the benefits of personalized medicine, which uses information about a person’s genes to tailor treatments accordingly. This has led to an increase in demand for disease risk and health genetic tests that can provide such information.
- Advances in technology: The rapid advances in technology are helping to drive growth in the market for disease risk and health genetic tests. For instance, new sequencing technologies are making it possible to sequence entire genomes quickly and cheaply, thus providing more comprehensive information on a person’s genes than ever before.
Scope Of The Report
Report Attributes
Report Details
Report Title
Disease Risk and Health Genetic Test Market Research Report
By Type
Celiac Disease, Parkinson Disease, Alzheimer Disease, Other
By Application
Online, Offline
By Companies
23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Disease Risk and Health Genetic Test Market Report Segments:
The global Disease Risk and Health Genetic Test market is segmented on the basis of:
Types
Celiac Disease, Parkinson Disease, Alzheimer Disease, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online, Offline
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 23andMe
- MyHeritage
- LabCorp
- Myriad Genetics
- Ancestry.com
- Quest Diagnostics
- Gene By Gene
- DNA Diagnostics Center
- Invitae
- IntelliGenetics
- Ambry Genetics
- Living DNA
- EasyDNA
- Pathway Genomics
- Centrillion Technology
- Xcode
- Color Genomics
- Anglia DNA Services
- African Ancestry
- Canadian DNA Services
- DNA Family Check
- Alpha Biolaboratories
- Test Me DNA
- 23 Mofang
- Genetic Health
- DNA Services of America
- Shuwen Health Sciences
- Mapmygenome
- Full Genomes
Highlights of The Disease Risk and Health Genetic Test Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Celiac Disease
- Parkinson Disease
- Alzheimer Disease
- Other
- By Application:
- Online
- Offline
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Disease Risk and Health Genetic Test Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A disease risk and health genetic test is a type of genetic test that can help identify whether an individual has a higher risk of developing certain diseases. This information can then be used to make decisions about lifestyle changes, such as diet and exercise, that may reduce the risk of developing these diseases.
Some of the key players operating in the disease risk and health genetic test market are 23andMe, MyHeritage, LabCorp, Myriad Genetics, Ancestry.com, Quest Diagnostics, Gene By Gene, DNA Diagnostics Center, Invitae, IntelliGenetics, Ambry Genetics, Living DNA, EasyDNA, Pathway Genomics, Centrillion Technology, Xcode, Color Genomics, Anglia DNA Services, African Ancestry, Canadian DNA Services, DNA Family Check, Alpha Biolaboratories, Test Me DNA, 23 Mofang, Genetic Health, DNA Services of America, Shuwen Health Sciences, Mapmygenome, Full Genomes.
The disease risk and health genetic test market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Disease Risk and Health Genetic Test Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Disease Risk and Health Genetic Test Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Disease Risk and Health Genetic Test Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Disease Risk and Health Genetic Test Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Disease Risk and Health Genetic Test Market Size & Forecast, 2018-2028 4.5.1 Disease Risk and Health Genetic Test Market Size and Y-o-Y Growth 4.5.2 Disease Risk and Health Genetic Test Market Absolute $ Opportunity
Chapter 5 Global Disease Risk and Health Genetic Test Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Disease Risk and Health Genetic Test Market Size Forecast by Type
5.2.1 Celiac Disease
5.2.2 Parkinson Disease
5.2.3 Alzheimer Disease
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Disease Risk and Health Genetic Test Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Disease Risk and Health Genetic Test Market Size Forecast by Applications
6.2.1 Online
6.2.2 Offline
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Disease Risk and Health Genetic Test Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Disease Risk and Health Genetic Test Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Disease Risk and Health Genetic Test Analysis and Forecast
9.1 Introduction
9.2 North America Disease Risk and Health Genetic Test Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Disease Risk and Health Genetic Test Market Size Forecast by Type
9.6.1 Celiac Disease
9.6.2 Parkinson Disease
9.6.3 Alzheimer Disease
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Disease Risk and Health Genetic Test Market Size Forecast by Applications
9.10.1 Online
9.10.2 Offline
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Disease Risk and Health Genetic Test Analysis and Forecast
10.1 Introduction
10.2 Europe Disease Risk and Health Genetic Test Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Disease Risk and Health Genetic Test Market Size Forecast by Type
10.6.1 Celiac Disease
10.6.2 Parkinson Disease
10.6.3 Alzheimer Disease
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Disease Risk and Health Genetic Test Market Size Forecast by Applications
10.10.1 Online
10.10.2 Offline
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Disease Risk and Health Genetic Test Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Disease Risk and Health Genetic Test Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Disease Risk and Health Genetic Test Market Size Forecast by Type
11.6.1 Celiac Disease
11.6.2 Parkinson Disease
11.6.3 Alzheimer Disease
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Disease Risk and Health Genetic Test Market Size Forecast by Applications
11.10.1 Online
11.10.2 Offline
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Disease Risk and Health Genetic Test Analysis and Forecast
12.1 Introduction
12.2 Latin America Disease Risk and Health Genetic Test Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Disease Risk and Health Genetic Test Market Size Forecast by Type
12.6.1 Celiac Disease
12.6.2 Parkinson Disease
12.6.3 Alzheimer Disease
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Disease Risk and Health Genetic Test Market Size Forecast by Applications
12.10.1 Online
12.10.2 Offline
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Market Size Forecast by Type
13.6.1 Celiac Disease
13.6.2 Parkinson Disease
13.6.3 Alzheimer Disease
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Disease Risk and Health Genetic Test Market Size Forecast by Applications
13.10.1 Online
13.10.2 Offline
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Disease Risk and Health Genetic Test Market: Competitive Dashboard
14.2 Global Disease Risk and Health Genetic Test Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 23andMe
14.3.2 MyHeritage
14.3.3 LabCorp
14.3.4 Myriad Genetics
14.3.5 Ancestry.com
14.3.6 Quest Diagnostics
14.3.7 Gene By Gene
14.3.8 DNA Diagnostics Center
14.3.9 Invitae
14.3.10 IntelliGenetics
14.3.11 Ambry Genetics
14.3.12 Living DNA
14.3.13 EasyDNA
14.3.14 Pathway Genomics
14.3.15 Centrillion Technology
14.3.16 Xcode
14.3.17 Color Genomics
14.3.18 Anglia DNA Services
14.3.19 African Ancestry
14.3.20 Canadian DNA Services
14.3.21 DNA Family Check
14.3.22 Alpha Biolaboratories
14.3.23 Test Me DNA
14.3.24 23 Mofang
14.3.25 Genetic Health
14.3.26 DNA Services of America
14.3.27 Shuwen Health Sciences
14.3.28 Mapmygenome
14.3.29 Full Genomes